Pharmacologic treatment of portal hypertension: Past, present, and future

被引：25

作者：

Boyer, TD ^{[1
]}

机构：

[1] Univ Arizona, Hlth Sci Ctr, Liver Res Inst, Tucson, AZ 85724 USA

来源：

HEPATOLOGY | 2001年 / 34卷 / 04期

关键词：

D O I：

10.1053/jhep.2001.27545

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：834 / 839

页数：6

共 45 条

[41] INJECTION SCLEROTHERAPY OF ESOPHAGEAL-VARICES [J].

TERBLANCHE, J ;

BORNMAN, PC ;

JONKER, MAT ;

KIRSCH, RE ;

SAUNDERS, SJ .

SEMINARS IN LIVER DISEASE, 1982, 2 (03) :233-241

[42]

TERBLANCHE J, 1979, SURG GYNECOL OBSTET, V148, P323

[43] Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding [J].

Villanueva, C ;

Balanzo, J ;

Novilla, MT ;

Soriano, G ;

Sainz, S ;

Torras, Z ;

Cusso, Z ;

Guarner, C ;

Vilardell, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (25) :1624-1629

[44] Nitric oxide and portal hypertension: Its role in the regulation of intrahepatic and splanchnic vascular resistance [J].

Wiest, R ;

Groszmann, RJ .

SEMINARS IN LIVER DISEASE, 1999, 19 (04) :411-426

[45] Gene transfer of the neuronal NO synthase isoform to cirrhotic fat liver ameliorates portal hypertension [J].

Yu, Q ;

Shao, R ;

Qian, HS ;

George, SE ;

Rockey, DC .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) :741-748

← 1 2 3 4 5 →